Arylpiperidines are a new class of oxidosqualene cyclase inhibitors.
They are steroidomimetic compounds mimicking cationic high energy intermediates.
Compound 29 has submicromolar activity on human OSC and high species selectivity.
This compound effectively reduces total cholesterol biosynthesis in a cellular assay.
A plausible binding mode is suggested on the basis of docking experiments.